Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1995
04/04/1995US5403848 Diagnosis and treatment of a disorder of the gastrointestinal tract
04/04/1995US5403847 Use of α1C specific compounds to treat benign prostatic hyperlasia
04/04/1995US5403845 Muscarinic agonists
04/04/1995US5403842 Benzopyran and benzothiopyran derivatives
04/04/1995US5403841 Administrable as drops that gel upon installation in the eye
04/04/1995US5403840 Inclusion complexes of N-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same
04/04/1995US5403837 Treating epilepsy, convulsions, schizophrenic and neurological disorders
04/04/1995US5403836 Anticoagulants
04/04/1995US5403834 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
04/04/1995US5403833 Methods of inhibiting transplant rejecton in mammals using rapamycin and derivatives and prodrugs thereof
04/04/1995US5403831 Method of treating and preventing loss of bone mass using 1α-hydroxy-vitamin D2
04/04/1995US5403830 Compositions and methods of treating gastrointestinal disorders
04/04/1995US5403829 Administering to promote formation of bone tissue
04/04/1995US5403827 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them
04/04/1995US5403824 Administering a opioid, opioid-degrading enzyme inhibitor or enkephalin secretagogues or mixtures thereof; side effect reduction
04/04/1995US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol
04/04/1995US5403595 Contains physical constraint modulation system contining microparticle of lobaline in a biodegradable polymer to release effective amount of lobaline to diminish indivisuals desire for nicotine for a period of time
04/04/1995US5403594 Oral spiramycin formulations and method for preparing same
04/04/1995US5403592 Lubricant composition for rheumatism
04/04/1995US5403591 Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives
04/04/1995US5403590 Method of pulsatile drug infusion
04/04/1995US5403575 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
04/04/1995CA2046910C Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
04/04/1995CA1335111C Olive oil purification process
04/04/1995CA1335105C 1.alpha.-hydroxyvitamin d2 epimer and derivatives
04/04/1995CA1335104C Diphenyl-3-azahexane and diphenyl-4-azaheptane derivatives, pharmaceutical compositions containing them and process for their preparation
04/04/1995CA1335103C 5'-indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted) phenyl-5beta- amidomethyloxazolidin-2-ones and 3-(nitrogen substituted) phenyl-5beta-amidomethyloxazolidin-2-ones
04/04/1995CA1335102C P-hydroxy phenone derivatives and drugs containing these
04/04/1995CA1335101C Benzamide compounds, process for preparing the same, and compositions for activating gastric motor function containing the same
04/04/1995CA1335079C Preventive and curative agents for acquired immune deficiency syndrome (aids)
04/04/1995CA1335078C Antiviral method for human immunodeficiency virus with bu-3608
04/02/1995CA2133115A1 Carboxylate derivatives exhibiting phospholipase a2 inhibitory activity
03/1995
03/31/1995CA2133180A1 Rapamycin formulation for iv injection
03/31/1995CA2133179A1 Rapamycin formulation for iv injection
03/31/1995CA2133174A1 Rapamycin formulations for oral administration
03/30/1995WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995WO1995008563A1 Glutathione analogs and paralog panels comprising glutathione mimics
03/30/1995WO1995008559A1 Novel urethane-containing aminosteroid compounds
03/30/1995WO1995008558A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
03/30/1995WO1995008557A1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
03/30/1995WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates
03/30/1995WO1995008552A1 Novel substituted propane-2-ol derivatives
03/30/1995WO1995008551A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer
03/30/1995WO1995008549A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/30/1995WO1995008547A1 Novel dihispidine derivatives, process for producing them and medicaments containing these compounds
03/30/1995WO1995008542A1 Farnesyltransferase inhibitor
03/30/1995WO1995008541A1 Conformationally locked nucleoside analogues
03/30/1995WO1995008540A1 Bis(amidinobenzimidazolyl)alkanes as antiviral agents
03/30/1995WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
03/30/1995WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents
03/30/1995WO1995008534A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
03/30/1995WO1995008532A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
03/30/1995WO1995008528A1 Triaryl-ethylene derivatives for use in therapy
03/30/1995WO1995008462A1 Hydraulic system for anti-lock braking installations in motor vehicles
03/30/1995WO1995008350A1 REGULATION OF bcl-2 GENE EXPRESSION
03/30/1995WO1995008344A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
03/30/1995WO1995008342A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
03/30/1995WO1995008334A1 Antimalarial
03/30/1995WO1995008333A1 Use of 2',5'-oligoadenylates for treatment of papillomatoses
03/30/1995WO1995008332A1 Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
03/30/1995WO1995008331A1 Enteric coated oral compositions containing bisphosphonic acid derivatives
03/30/1995WO1995008330A1 Transdermal therapeutic system with acetylsalicylic acid as active substance
03/30/1995WO1995008329A1 Methods for the reduction of postmenopausal ldl cholesterol
03/30/1995WO1995008327A1 Method for inhibiting angiogenesis
03/30/1995WO1995008326A1 Protein kinase c activators and their use in decreasing expression of cell antigens
03/30/1995WO1995008325A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
03/30/1995WO1995008324A1 Volatile active substance containing plaster that may be produced without solvents
03/30/1995WO1995008323A1 Budesonide pellets with a controlled release pattern and process for producing them
03/30/1995WO1995005181A3 Drug for parasitic control of animals
03/30/1995WO1995001793A3 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain
03/30/1995WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
03/30/1995WO1994026113A3 Pour-on formulations containinng polymeric material, glycols and glycerides
03/30/1995CA2182530A1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
03/30/1995CA2172605A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
03/30/1995CA2172529A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
03/30/1995CA2172497A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
03/30/1995CA2172495A1 Novel urethane-containing aminosteroid compounds
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172383A1 Protein kinase c activators and their use in decreasing expression of cell antigens
03/30/1995CA2172256A1 New bishispidine derivatives, processes for their production and pharmaceutical agents containing these compounds
03/30/1995CA2172147A1 2',5'-oligoadenylate-2',3'-cyclophosphates
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995CA2171448A1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
03/30/1995CA2148607A1 Antimalarial drug
03/30/1995CA2132896A1 Pharmaceutical compounds
03/30/1995CA2129282A1 Method for the treatment of neoplastic disease utilizing taxol and tiazofurin
03/29/1995EP0645391A2 Aminobenzoic acid derivatives
03/29/1995EP0645390A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation
03/29/1995EP0645388A1 Process for the production of imidazopyridines
03/29/1995EP0645385A1 Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
03/29/1995EP0645378A1 Condensed seven- or eight-membered heterocyclic compounds useful as squalene synthetase inhibitors
03/29/1995EP0645377A1 Benzoxazepine derivatives useful as squalene synthetase inhibitors
03/29/1995EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists
03/29/1995EP0645375A1 Use of benzene-sulfonyl-indole derivatives for the preparation of a medicament
03/29/1995EP0645370A1 Substituted m-xylylene diamines for the treatment of diseases of the central nervous system
03/29/1995EP0645145A2 Stabilized pharmaceutical composition and stabilizing solvent
1 ... 7030 7031 7032 7033 7034 7035 7036 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 ... 7860